Novo Nordisk
NVO
#26
Rank
A$614.63 B
Marketcap
$136.08
Share price
0.92%
Change (1 day)
-17.44%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): A$26.50 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are A$39.69 Billion. In 2023 the company made an earning of A$24.75 Billion, an increase over its 2022 earnings that were of A$15.70 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$26.50 B7.05%
2023 A$24.75 B57.64%
2022 A$15.70 B5.35%
2021 A$14.90 B12.47%
2020 A$13.25 B13.07%
2019 A$11.72 B-3.35%
2018 A$12.12 B1.79%
2017 A$11.91 B4.52%
2016 A$11.40 B9.42%
2015 A$10.41 B8.24%
2014 A$9.62 B3.45%
2013 A$9.30 B19.02%
2012 A$7.81 B15.21%
2011 A$6.78 B17.71%
2010 A$5.76 B24.78%
2009 A$4.62 B10.62%
2008 A$4.17 B55.97%
2007 A$2.67 B7.07%
2006 A$2.50 B18.18%
2005 A$2.11 B11.33%
2004 A$1.90 B
2002 A$1.16 B-14.39%
2001 A$1.35 B-52.82%
2000 A$2.87 B250%
1999 A$0.82 B31.21%
1998 A$0.62 B34.31%
1997 A$0.46 B11.46%
1996 A$0.41 B9.03%
1995 A$0.38 B-3.15%
1994 A$0.39 B-0.67%
1993 A$0.39 B45.38%
1992 A$0.27 B-13.81%
1991 A$0.31 B37.12%
1990 A$0.23 B-0.79%
1989 A$0.23 B26.2%
1988 A$0.18 B24.97%
1987 A$0.14 B-0.9%
1986 A$0.14 B-7.78%
1985 A$0.16 B24.87%
1984 A$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$11.14 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.28 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$11.04 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.88 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France